Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
Viral Eradication / 2-log Drop
Does Retreatment with Interferon Alfacon (Infergen) Plus Interferon Gamma (Actimmune) Benefit Nonresponders to Peginterferon Plus Ribavirin?
- 5/27/05
Experimental HCV Protease Inhibitor VX-950 Demonstrates Potent Anti-HCV Activity
- 05/11/05
Effects of Triple Combination Therapy with Merimepodib/Peginterferon Alfa/Ribavirin on Prior Nonresponders to Peginterferon/ Ribavirin
- 11/04/04
In a US Cohort the Large Majority of Individuals with Acute Hepatitis C Experience Spontaneous or Therapy-induced Viral Clearance
- 05/19/04
HCV NS3 and NS4 Proteins Contain Epitopes Associated with Spontaneous Viral Clearance
10/29/03
Development of HCV-specific T Cells in HCV-exposed, HCV-Seronegative Individuals
10/29/03
Immune Responses to NS3 Regions Crucial in HCV Clearance
03/14/03
Clinical Correlates of HCV Genotype and Viral Load: Findings from the WIN-R Trial
1/15/03
Decline in HCV RNA May Predict Spontaneous Clearance
1/13/03
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
